GENES FOR INTERLEUKIN-1, INTERLEUKIN-6, AND TUMOR-NECROSIS-FACTOR ARE EXPRESSED AT MARKEDLY REDUCED LEVELS IN THE LIVERS OF PATIENTS WITH SEVERE LIVER-DISEASE

被引:26
作者
TOVEY, MG
GUGENHEIM, J
GUYMARHO, J
BLANCHARD, B
VANDENBROECKE, C
GRESSER, I
BISMUTH, H
REYNES, M
机构
[1] Laboratory of Viral Oncology (UPR 274), Centre National de la Recherche Scientifique, 94801, Villejuif, 7, rue Guy Mocquet
[2] Laboratoire de Recherches Chirurgicales, Faculté de Nice, 06100, Nice, Avenue de Vallombrose
[3] Höpital Paul-Brousse, 94800, Villejuif
关键词
INTERFERON; CYTOKINES; TRANSCRIPTION; GENE EXPRESSION;
D O I
10.3109/08916939109001904
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The genes for interferon (IFN) α IFN γ IL-1 β IL-6, and TNF α were transcribed at readily detectable levels both in liver biopsies from individuals with normal liver function and in samples of normal viable liver taken for transplantation. These results provided evidence for the concept that such multifunctional cytokines play a role in homeostasis in normal human tissues. In normal human liver, in situ hybridization studies showed that, in the absence of a detectable inflammatory response, both heptocytes and mononuclear cells exhibited a similar degree of expression of IL-6 mRNA in keeping with the finding that IL-6 is produced by cells of different lineages. The levels of IL-1, IL-6, and TNF mRNA were found to be markedly reduced in extracts of the livers of patients with primary biliary cirrhosis and other forms of autommune liver disease at a time when extensive liver lesions were apparent, compared to the levels of expression of these cytokines in the livers of normal individuals. The reduced expression of IL-1, IL-6, and TNF mRNAs appeared to be a specific effect and not due to a general reduction in RNA synthesis as the IFN α IFN γ and actin mRNAs were expressed at similar levels in both normal and diseased livers. The levels of IL-1 β IL-6, and TNF mRNAs were also reduced in samples of liver from a patient with a drug induced fulminant hepatitis suggesting that this specific pattern of altered cytokine gene expression was characteristic of the advanced stage of severe liver disease. © 1991 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:297 / 310
页数:14
相关论文
共 57 条
[1]  
Tovey M.G., Expression of the genes of interferons and other cytokines in normal and diseased tissues of man, Experientia, 45, pp. 526-535, (1989)
[2]  
Schattner M., Interferons and autoimmunity, The American J of the Medical Sciences, 295, pp. 532-544, (1988)
[3]  
Sinha A.A., Lopez M.T., McDevitt H.O., Autoimmune diseases: the failure of self tolerance, Science, 248, pp. 1380-1388, (1990)
[4]  
Tovey M.G., Streuli M., Gresser I., Gugenheim J., Blanchard B., Guymarho J., Et al., Interferon messenger RNA is produced constitutively in the organs of normal individuals, Proc Natl Acad Sci USA, 84, pp. 5038-5042, (1987)
[5]  
Tovey M.G., Content J., Gresser I., Gugenheim J., Blanchard B., Guymarho J., Et al., Genes for IFN-β-2 (1L-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individuals, J Immunol, 141, pp. 3106-3110, (1988)
[6]  
Hooks J.J., Moutsopoulos H.H., Gies D.S.A., Stahl N.I., Decker J.L., Notkins A.L., Immune interferon in the circulation of patients with autoimmune disease, N Engl J Med, 301, pp. 5-8, (1979)
[7]  
Panem S., Ordonez N., Vilcek J., Renal deposition of alpha interferon in systemic lupus erythematosus, Inf Immun, 42, pp. 368-373, (1983)
[8]  
Kim T., Kanamaya Y., Negor N., Okamura M., Takeda T., Inoue T., Serum levels of interferons in patients with systemic lupus erythematosus, Clin Exp Immun, 70, pp. 562-569, (1987)
[9]  
Zoumbos N.C., Gascon P., Djeu J.Y., Young N.S., Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo, Proc Natl Acad Sci USA, 82, pp. 188-192, (1985)
[10]  
De Stefano E., Friedman R.M., Friedman-Kien A.E., Godert J.J., Henriksen D., Preble O.T., Et al., Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy, J Infec Diseases, 146, pp. 451-455, (1982)